PeptideDB

Griselimycin

CAS: 26034-16-2 F: C57H96N10O12 W: 1113.43

Griselimycin is a compound with antituberculosis activity that exhibits good in vitro and in vivo activity against sensi
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Griselimycin is a compound with antituberculosis activity that exhibits good in vitro and in vivo activity against sensitive and resistant Mycobacterium tuberculosis, and its cyclohexyl derivative has high transformative potential.
CAS 26034-16-2
Formula C57H96N10O12
Molar Mass 1113.43
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. New Griselimycins for Treatment of Tuberculosis